cerca CERCA
Venerdì 08 Novembre 2024
Aggiornato: 00:13
10 ultim'ora BREAKING NEWS

SALUTE E BENESSERE

comunicato stampa

The FHH Forum 2023, which was held yesterday in Geneva, on the theme "Horology Futurology", proved to be a crossroads of avant-garde ideas and constructive debate, guided by exchanges and in-depth discussions with renowned experts

GENEVA, Nov. 13, 2023 /PRNewswire/ -- The Fondation Haute Horlogerie successfully hosted the 11th edition of the FHH Forum at the Maison de la Paix yesterday in Geneva. Under the evocative theme "Horology Futurology", the event saw the participation of around 200 people. The day echoed the mission of the FHH Forum: to ensure the sustainability and adaptability of the watch industry by fostering dialogue and debate. Delphine Bachmann - State Councilor of the Canton of Geneva, Sami Kanaan - Member ...

Chirurgia-estetica-filler

Chirurgia estetica, filler e sicurezza: la parola al dott. Della Corte

Napoli, 10/11/2023 - Negli ultimi anni sempre più persone, uomini e donne, ricorrono all'aiuto della chirurgia estetica per sentirsi più a proprio agio con il proprio aspetto. Il periodo post-pandemico, inoltre, pare abbia notevolmente aumentato questa tendenza: il connubio sedentarietà e vita in casa ha infatti spinto gran parte della gente a riflettere sulla propria condizione fisica.

comunicato stampa

European Wellness and DXN Sign MoU to Establish World-Class Wellness Centre!

CYBERJAYA, Malaysia, Nov. 9, 2023 /PRNewswire/ -- European Wellness Biomedical Group (EW Group) has signed a Memorandum of Understanding with DXN Holdings Berhad (DXN) to jointly develop and establish a comprehensive wellness centre that draws from the extensive expertise and experience of both parties.

comunicato stampa

Gruppo Menarini e SciClone Pharmaceuticals annunciano un accordo esclusivo di sublicenza per sviluppare e commercializzare ORSERDU® (Elacestrant) in Cina per affrontare il tumore al seno avanzato o metastatico

FIRENZE, Italia e HONG KONG, 8 novembre 2023 /PRNewswire/ -- Il Gruppo Menarini ("Menarini"), azienda leader a livello internazionale nel settore farmaceutico e diagnostico, e SciClone Pharmaceuticals (Holdings) Ltd. ("SciClone"), azienda biofarmaceutica internazionale, hanno annunciato oggi di aver stipulato un accordo esclusivo di sublicenza per lo sviluppo e la commercializzazione di ORSERDU® (elacestrant) nella Repubblica popolare cinese (Cina), nel tentativo di ampliare le opzioni di trattam...

comunicato stampa

Kexing Biopharm Attended CPHI Worldwide 2023

SHENZHEN, China, Nov. 7, 2023 /PRNewswire/ -- Recently, CPHI Worldwide 2023 was successfully held in Barcelona, Spain. Kexing Biopharm exhibited more than ten kinds of high-quality medical products in the fields of tumor, autoimmune, anti-virus, etc., including Infliximab, Adalimumab, Bevacizumab, and Trastuzumab, etc., which attracted many customers to stop by for negotiation.

comunicato stampa

Registration for the 7th IFPA Conference 2024 now open

STOCKHOLM, Nov. 7, 2023 /PRNewswire/ -- IFPA (International Federation of Psoriasis Associations) is thrilled to announce the 7th IFPA Conference (former World Psoriasis & Psoriatic Arthritis Conference), set to take place from June 27 to 29, 2024, in the vibrant city of Stockholm, Sweden. Established in 2006, the IFPA Conference is a pivotal event providing a unique cross-specialty platform that brings together medical and health professionals from various disciplines to share groundbreaking cli...



SEGUICI SUI SOCIAL



threads whatsapp linkedin twitter youtube facebook instagram
ora in
Prima pagina
articoli
in Evidenza